Cardiovascular Disease

New Data Confirms Safety And Tolerability Of Pravachol

Published in Diabetes Week, October 1st, 2001

Analysis from three landmark clinical trials provide further confirmation regarding the safety and tolerability profile of pravastatin.

The results of the "Prospective Pravastatin Pooling Project (PPP); The Tolerability and Safety of Pravastatin Based on 112,000 Patient Year Experience in Placebo-Controlled Trials" were presented September 3, 2001, at the XXIII Congress of the European Society of Cardiology meeting held in Stockholm, Sweden.

"The Prospective Pravastatin Pooling Project provides physicians and patients with a wealth of quantitative data from three major international trials regarding the safety of this compound," said Marc A. Pfeffer,...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Diabetes Week

Source: Diabetes Week (2001-10-01)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry